$USAU
US Gold Corp Stock $usau

$usau Overview Financials Valuation SEC Filings Company Website

2023 Q3 Form 10-Q Financial Statement

#000149315223032603 Filed on September 14, 2023

Income Statement

Concept	2023 Q3	2023 Q2	2022 Q3
Revenue		$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$2.080M	$1.877M	$2.123M
YoY Change	-2.0%	-3.29%	23.52%
% of Gross Profit
Research & Development	$840.0K	$253.2K	$762.9K
YoY Change	10.11%	-69.6%	-58.34%
% of Gross Profit
Depreciation & Amortization	$8.237K	$8.050K	$11.58K
YoY Change	-28.87%	-12.69%	45.66%
% of Gross Profit
Operating Expenses	$2.930M	$2.137M	$2.885M
YoY Change	1.55%	-22.97%	-18.72%
Operating Profit	-$2.930M		-$2.885M
YoY Change	1.55%		-18.72%
Interest Expense	$10.00K	$800.1K	$940.0K
YoY Change	-98.94%	-33.99%
% of Operating Profit
Other Income/Expense, Net	$35.43K	-$542.0K	$940.0K
YoY Change	-96.23%	-153.08%
Pretax Income	-$2.895M	-$1.879M	-$1.945M
YoY Change	48.8%	7.18%	-45.2%
Income Tax		$0.00
% Of Pretax Income
Net Earnings	-$2.900M	-$1.879M	-$1.900M
YoY Change	52.63%	7.18%	-46.47%
Net Earnings / Revenue
Basic Earnings Per Share	-$0.31		-$0.23
Diluted Earnings Per Share	-$0.31	-$0.22	-$233.0K
COMMON SHARES
Basic Shares Outstanding	9.294M shares		8.350M shares
Diluted Shares Outstanding	9.296M shares		8.350M shares

Balance Sheet

Concept	2023 Q3	2023 Q2	2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$6.010M	$7.823M	$6.318M
YoY Change	-4.87%	-14.14%	-41.35%
Cash & Equivalents	$6.014M	$7.823M	$6.318M
Short-Term Investments
Other Short-Term Assets	$500.0K	$610.1K	$869.9K
YoY Change	-42.52%	-22.56%	4.2%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$6.518M	$8.433M	$7.188M
YoY Change	-9.32%	-14.81%	-38.08%
LONG-TERM ASSETS
Property, Plant & Equipment	$482.7K	$490.9K	$338.3K
YoY Change	42.66%	40.3%	-97.96%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$850.0K	$857.5K	$832.5K
YoY Change	2.1%	3.0%	0.0%
Total Long-Term Assets	$15.72M	$15.75M	$17.58M
YoY Change	-10.59%	-10.52%	1.08%
TOTAL ASSETS
Total Short-Term Assets	$6.518M	$8.433M	$7.188M
Total Long-Term Assets	$15.72M	$15.75M	$17.58M
Total Assets	$22.23M	$24.18M	$24.77M
YoY Change	-10.22%	-12.07%	-14.59%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.130M	$346.7K	$1.044M
YoY Change	8.22%	-67.91%	-20.53%
Accrued Expenses	$20.00K	$32.08K	$42.83K
YoY Change	-53.3%	-42.33%	135.98%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$1.147M	$378.8K	$1.087M
YoY Change	5.48%	-66.66%	-18.4%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$4.500M	$4.517M	$1.775M
YoY Change	153.49%	66.73%	690.73%
Total Long-Term Liabilities	$4.933M	$4.947M	$1.775M
YoY Change	177.87%	82.62%	690.74%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.147M	$378.8K	$1.087M
Total Long-Term Liabilities	$4.933M	$4.947M	$1.775M
Total Liabilities	$6.079M	$5.326M	$2.862M
YoY Change	112.4%	38.52%	83.87%
SHAREHOLDERS EQUITY
Retained Earnings	-$68.80M	-$66.00M	-$59.90M
YoY Change	14.86%	13.99%
Common Stock	$9.296K	$9.296K	$8.350K
YoY Change	11.33%	11.33%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$16.16M	$18.86M	$21.90M
YoY Change
Total Liabilities & Shareholders Equity	$22.23M	$24.18M	$24.77M
YoY Change	-10.22%	-12.07%	-14.59%

Cashflow Statement

Concept	2023 Q3	2023 Q2	2022 Q3
OPERATING ACTIVITIES
Net Income	-$2.900M	-$1.879M	-$1.900M
YoY Change	52.63%	7.18%	-46.47%
Depreciation, Depletion And Amortization	$8.237K	$8.050K	$11.58K
YoY Change	-28.87%	-12.69%	45.66%
Cash From Operating Activities	-$1.800M	-$2.289M	-$2.800M
YoY Change	-35.71%	-17.84%	-2.42%
INVESTING ACTIVITIES
Capital Expenditures		$0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities		$0.00
YoY Change
Cash From Investing Activities		$0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities		4.830M
YoY Change		-41.25%
NET CHANGE
Cash From Operating Activities	-$1.800M	-2.289M	-$2.800M
Cash From Investing Activities		0.000
Cash From Financing Activities		4.830M
Net Change In Cash	-$1.809M	2.540M	-$2.794M
YoY Change	-35.26%	-53.25%	-2.76%
FREE CASH FLOW
Cash From Operating Activities	-$1.800M	-$2.289M	-$2.800M
Capital Expenditures		$0.00
Free Cash Flow		-$2.289M	-$2.800M
YoY Change		-17.84%	-2.29%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q3	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2023Q3	dei	Entity Central Index Key EntityCentralIndexKey	0000027093
CY2023Q3	dei	Amendment Flag AmendmentFlag	false
CY2023Q3	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--04-30
CY2023Q3	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q3	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2023Q2	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax		usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax		usd
CY2022Q3	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1		usd
CY2022Q3	us-gaap	Investment Income Net InvestmentIncomeNet		usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022Q3	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1		usd
CY2022Q3	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets		usd
CY2023Q3	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2022Q3	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2023Q3	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2022Q3	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2023	us-gaap	Asset Retirement Obligation Revision Of Estimate AssetRetirementObligationRevisionOfEstimate		usd
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross		shares
CY2023Q3	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2023Q3	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
CY2023Q3	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod		shares
CY2023Q3	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod		shares
CY2023Q3	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
CY2023Q3	USAU	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable Weighted Average Fair Value Of Warrants Granted Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageFairValueOfWarrantsGrantedExercisePrice
CY2023Q3	dei	Document Type DocumentType	10-Q
CY2023Q3	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q3	dei	Document Period End Date DocumentPeriodEndDate	2023-07-31
CY2023Q3	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q3	dei	Entity File Number EntityFileNumber	001-08266
CY2023Q3	dei	Entity Registrant Name EntityRegistrantName	U.S. GOLD CORP.
CY2023Q3	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2023Q3	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	22-1831409
CY2023Q3	dei	Entity Address Address Line1 EntityAddressAddressLine1	1910 E. Idaho Street
CY2023Q3	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 102-Box 604
CY2023Q3	dei	Entity Address City Or Town EntityAddressCityOrTown	Elko
CY2023Q3	dei	Entity Address State Or Province EntityAddressStateOrProvince	NV
CY2023Q3	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	89801
CY2023Q3	dei	City Area Code CityAreaCode	(800)
CY2023Q3	dei	Local Phone Number LocalPhoneNumber	557-4550
CY2023Q3	dei	Security12b Title Security12bTitle	Common Stock
CY2023Q3	dei	Trading Symbol TradingSymbol	USAU
CY2023Q3	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023Q3	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q3	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q3	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q3	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q3	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q3	dei	Entity Shell Company EntityShellCompany	false
CY2023Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	9295837	shares
CY2023Q3	us-gaap	Cash Cash	6014188	usd
CY2023Q2	us-gaap	Cash Cash	7822930	usd
CY2023Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	503806	usd
CY2023Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	610140	usd
CY2023Q3	us-gaap	Assets Current AssetsCurrent	6517994	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	8433070	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	482688	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	490925	usd
CY2023Q3	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	845335	usd
CY2023Q2	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	857509	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	18336	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	32080	usd
CY2023Q3	us-gaap	Mineral Rights MineralRights	14370255	usd
CY2023Q2	us-gaap	Mineral Rights MineralRights	14370255	usd
CY2023Q3	us-gaap	Assets Noncurrent AssetsNoncurrent	15716614	usd
CY2023Q2	us-gaap	Assets Noncurrent AssetsNoncurrent	15750769	usd
CY2023Q3	us-gaap	Assets Assets	22234608	usd
CY2023Q2	us-gaap	Assets Assets	24183839	usd
CY2023Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1128262	usd
CY2023Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	346718	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	18336	usd
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	32080	usd
CY2023Q3	us-gaap	Liabilities Current LiabilitiesCurrent	1146598	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	378798	usd
CY2023Q3	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	4215900	usd
CY2023Q2	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	4230850	usd
CY2023Q3	us-gaap	Asset Retirement Obligations Noncurrent AssetRetirementObligationsNoncurrent	286433	usd
CY2023Q2	us-gaap	Asset Retirement Obligations Noncurrent AssetRetirementObligationsNoncurrent	285764	usd
CY2023Q3	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	430486	usd
CY2023Q2	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	430486	usd
CY2023Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	4932819	usd
CY2023Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	4947100	usd
CY2023Q3	us-gaap	Liabilities Liabilities	6079417	usd
CY2023Q2	us-gaap	Liabilities Liabilities	5325898	usd
CY2023Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2023Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2023Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	9295837	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	9295837	shares
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	9295837	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	9295837	shares
CY2023Q3	us-gaap	Common Stock Value CommonStockValue	9296	usd
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	9296	usd
CY2023Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	84991196	usd
CY2023Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	84799263	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-68845301	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-65950618	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	16155191	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	18857941	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	22234608	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	24183839	usd
CY2023Q3	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	412839	usd
CY2022Q3	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	402805	usd
CY2023Q3	us-gaap	Exploration Expense ExplorationExpense	841541	usd
CY2022Q3	us-gaap	Exploration Expense ExplorationExpense	762861	usd
CY2023Q3	us-gaap	Professional Fees ProfessionalFees	1345962	usd
CY2022Q3	us-gaap	Professional Fees ProfessionalFees	1325791	usd
CY2023Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	329773	usd
CY2022Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	393901	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	2930115	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	2885358	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-2930115	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-2885358	usd
CY2023Q3	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	6075	usd
CY2023Q3	us-gaap	Investment Income Net InvestmentIncomeNet	14407	usd
CY2023Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-14950	usd
CY2022Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-940000	usd
CY2023Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	35432	usd
CY2022Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	940000	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2894683	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1945358	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-2894683	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-1945358	usd
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.31
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.31
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.23
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.23
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9295837	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9295837	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	8349843	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	8349843	shares
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	18857941	usd
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	7402	usd
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition	184531	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-2894683	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	16155191	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	23227315	usd
CY2022Q3	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	7402	usd
CY2022Q3	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition	184531	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-1945358	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	21473890	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-2894683	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-1945358	usd
CY2023Q3	us-gaap	Depreciation Depreciation	8237	usd
CY2022Q3	us-gaap	Depreciation Depreciation	11580	usd
CY2023Q3	us-gaap	Accretion Expense AccretionExpense	6744	usd
CY2022Q3	us-gaap	Accretion Expense AccretionExpense	6274	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	13744	usd
CY2022Q3	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	12723	usd
CY2023Q3	us-gaap	Share Based Compensation ShareBasedCompensation	191933	usd
CY2022Q3	us-gaap	Share Based Compensation ShareBasedCompensation	191933	usd
CY2023Q3	USAU	Amortization Of Prepaid Stock Based Expenses AmortizationOfPrepaidStockBasedExpenses	47500	usd
CY2022Q3	USAU	Amortization Of Prepaid Stock Based Expenses AmortizationOfPrepaidStockBasedExpenses	99250	usd
CY2023Q3	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	6075	usd
CY2023Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-14950	usd
CY2022Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-940000	usd
CY2023Q3	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-58834	usd
CY2022Q3	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	181197	usd
CY2023Q3	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	-12174	usd
CY2023Q3	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	781544	usd
CY2022Q3	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-36212	usd
CY2023Q3	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-13744	usd
CY2022Q3	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-12798	usd
CY2023Q3	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1808742	usd
CY2022Q3	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2793805	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1808742	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2793805	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	7822930	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	9111512	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	6014188	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	6317707	usd
CY2022Q1	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	625000	shares
CY2023Q2	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	870000	shares
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	32080	usd
CY2023Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P0Y5M1D
CY2023Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.080	pure
CY2023Q3	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84C_eus-gaap--UseOfEstimates_zTG3nysjiKEd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Use of Estimates and Assumptions</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In preparing the unaudited condensed consolidated financial statements, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of the consolidated balance sheet, and revenues and expenses for the period then ended. Actual results may differ significantly from those estimates. Significant estimates made by management include, but are not limited to, valuation of mineral rights, stock-based compensation, the fair value of common stock, valuation of warrant liability, asset retirement obligations and the valuation of deferred tax assets and liabilities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q3	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p id="xdx_84B_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zamwRoiYqZ69" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Revision of Financial Statements</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the fiscal year ended April 30, 2021 (“fiscal year 2021”), the Company determined that it had not appropriately recorded a deferred tax liability related to the acquisition of mineral rights in August 2020. This resulted in an understatement of deferred tax liability and a corresponding understatement of provision for income taxes during fiscal year 2021. Based on an analysis of Accounting Standards Codification ASC 250 – “Accounting Changes and Error Corrections” (“ASC 250”), Staff Accounting Bulletin 99 – “Materiality” and Staff Accounting Bulletin 108 – “Considering the Effects of Prior Year Misstatements when Quantifying Misstatements in Current Year Financial Statements,” the Company determined that these errors were immaterial to the previously issued consolidated financial statements, and as such no restatement was necessary. Correcting prior period financial statements for immaterial errors would not require previously filed reports to be amended.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>U.S. GOLD CORP. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>JULY 31, 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_891_eus-gaap--ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock_zolfPgfgZYLb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The effect of this revision on the line items within the Company’s unaudited condensed consolidated statements of changes in stockholders’ equity as of the fiscal year ended April 30, 2022 (“fiscal year 2022”), was as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B9_zwjpkT5FUEwf" style="display: none">SCHEDULE OF REVISION OF FINANCIAL STATEMENT</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="10" style="border-bottom: Black 1.5pt solid; text-align: center">April 30, 2022</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_492_20220430__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z2flzpnsVPhd" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="margin-top: 0; margin-bottom: 0"></p> <p style="margin-top: 0; margin-bottom: 0">As Previously Reported</p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_491_20220430__srt--RestatementAxis__srt--RestatementAdjustmentMember_zpkVTHmIZmI1" style="border-bottom: Black 1.5pt solid; text-align: center">Revision</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49E_20220430_zB7xZrkkDnK2" style="border-bottom: Black 1.5pt solid; text-align: center">As Revised</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_407_eus-gaap--RetainedEarningsAccumulatedDeficit_iI_zpB4VdVUDs5a" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 49%; text-align: left">Accumulated Deficit</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 15%; text-align: right">(57,905,928</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right">(430,486</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right">(58,336,414</td><td style="width: 1%; text-align: left">)</td></tr> <tr id="xdx_404_eus-gaap--StockholdersEquity_iI_zpyfehSj4m5g" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Total Stockholders’ Equity</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">23,657,801</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(430,486</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">23,227,315</td><td style="text-align: left"> </td></tr> </table> <p id="xdx_8A3_zUyVFSazun9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-58336414	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	23227315	usd
CY2021Q3	us-gaap	Payments For Rent PaymentsForRent	3100	usd
CY2022Q1	us-gaap	Payments For Rent PaymentsForRent	2950	usd
CY2021Q3	us-gaap	Lessee Operating Lease Renewal Term LesseeOperatingLeaseRenewalTerm	P2Y
CY2021Q3	us-gaap	Lessee Operating Lease Option To Extend LesseeOperatingLeaseOptionToExtend	The Company is currently negotiating a two-year lease extension effective September 1, 2023.
CY2023Q3	us-gaap	Operating Lease Expense OperatingLeaseExpense	14267	usd
CY2022Q3	us-gaap	Operating Lease Expense OperatingLeaseExpense	14039	usd
CY2023Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q3	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2023Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	503806	usd
CY2023Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	610140	usd
CY2023Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	184531	usd
CY2022Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	184531	usd
CY2023Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	477042	usd
CY2023Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P0Y4M20D
CY2023Q3	USAU	Number Of Restrictred Stock Units Awarded But Unissued NumberOfRestrictredStockUnitsAwardedButUnissued	347146	shares
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	18336	usd
CY2023Q3	us-gaap	Cash Cash	6000000.0	usd
CY2023Q3	USAU	Working Capital WorkingCapital	5400000	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-68800000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-2900000	usd
CY2023Q3	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1800000	usd
CY2023Q3	us-gaap	Mineral Rights MineralRights	14370255	usd
CY2023Q2	us-gaap	Mineral Rights MineralRights	14370255	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	32080	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	18336	usd
CY2023Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	599297	usd
CY2023Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	602796	usd
CY2023Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	116609	usd
CY2023Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	111871	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	482688	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	490925	usd
CY2023Q3	us-gaap	Depreciation Depreciation	8237	usd
CY2022Q3	us-gaap	Depreciation Depreciation	11580	usd
CY2023Q2	us-gaap	Asset Retirement Obligations Noncurrent AssetRetirementObligationsNoncurrent	285764	usd
CY2022Q2	us-gaap	Asset Retirement Obligations Noncurrent AssetRetirementObligationsNoncurrent	260196	usd
CY2023Q3	us-gaap	Asset Retirement Obligation Revision Of Estimate AssetRetirementObligationRevisionOfEstimate	-6075	usd
CY2023Q3	us-gaap	Accretion Expense AccretionExpense	6744	usd
CY2023	us-gaap	Accretion Expense AccretionExpense	25568	usd
CY2023Q3	us-gaap	Asset Retirement Obligations Noncurrent AssetRetirementObligationsNoncurrent	286433	usd
CY2023Q2	us-gaap	Asset Retirement Obligations Noncurrent AssetRetirementObligationsNoncurrent	285764	usd
CY2023Q3	us-gaap	Accretion Expense AccretionExpense	6744	usd
CY2022Q3	us-gaap	Accretion Expense AccretionExpense	6274	usd
CY2021Q2	us-gaap	Lessee Operating Lease Description LesseeOperatingLeaseDescription	The initial term of the lease was for a two-year period from May 2021 to May 2023 starting with a monthly base rent of $1,667.
CY2021Q2	us-gaap	Payments For Rent PaymentsForRent	1667	usd
CY2023Q1	us-gaap	Lessee Operating Lease Option To Extend LesseeOperatingLeaseOptionToExtend	On January 30, 2023, the Company entered into a lease amendment effective as of May 1, 2023, to extend this lease for a period of one year expiring April 30, 2024 with an option to renew the lease for an additional one-year term.
CY2023Q1	us-gaap	Payments For Rent PaymentsForRent	1768	usd
CY2023Q1	USAU	Right Of Use Asset Obtained In Exchange For Operating Lease Liability Modification RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityModification	20472	usd
CY2023Q1	USAU	Operating Lease Incremetal Borrowing Rate OperatingLeaseIncremetalBorrowingRate	0.08	pure
CY2021Q3	us-gaap	Lessee Operating Lease Description LesseeOperatingLeaseDescription	The term of the lease is for a two-year period from September 2021 through August 2023.
CY2023Q3	USAU	Schedule Of Supplemental Cash Flow And Noncash Information Related To Leases ScheduleOfSupplementalCashFlowAndNoncashInformationRelatedToLeases	<p id="xdx_894_ecustom--ScheduleOfSupplementalCashFlowAndNoncashInformationRelatedToLeases_zBI5c9vSJsy9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table includes supplemental cash and non-cash information related to the Company’s lease:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #212529"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B1_zOlcVGJQvj28" style="display: none">SCHEDULE OF SUPPLEMENTAL CASH AND NON-CASH INFORMATION</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_490_20230501__20230731_z9QcMKhjiva9" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_495_20220501__20220731_zlWqNus72ZR8" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Period ended July 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Cash paid for amounts included in the measurement of lease liabilities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--OperatingLeasePayments_zn4vn2AO5ege" style="vertical-align: bottom; background-color: White"> <td style="width: 60%; text-align: left">Operating cash flows from operating lease</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">14,157</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">14,000</td><td style="width: 1%; text-align: left"> </td></tr> </table>
CY2023Q3	us-gaap	Operating Lease Payments OperatingLeasePayments	14157	usd
CY2022Q3	us-gaap	Operating Lease Payments OperatingLeasePayments	14000	usd
CY2023	USAU	Consulting Fees ConsultingFees	120000	usd
CY2022	USAU	Consulting Fees ConsultingFees	120000	usd
CY2023Q3	USAU	Warrant Liability WarrantLiability	4215900	usd
CY2023Q2	USAU	Warrant Liability WarrantLiability	4230850	usd
CY2022Q1	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	625000	shares
CY2023Q2	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	3088500	usd
CY2023Q3	USAU	Share Based Compensation Arrangement By Share Based Payment Non Option Award Fair Value Assumptions Stock Price ShareBasedCompensationArrangementByShareBasedPaymentNonOptionAwardFairValueAssumptionsStockPrice	4.48
CY2023Q3	USAU	Share Based Compensation Arrangement By Share Based Payment Non Option Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentNonOptionAwardFairValueAssumptionsExercisePrice	6.16
CY2023Q2	USAU	Share Based Compensation Arrangement By Share Based Payment Non Option Award Fair Value Assumptions Stock Price ShareBasedCompensationArrangementByShareBasedPaymentNonOptionAwardFairValueAssumptionsStockPrice	4.31
CY2023Q2	USAU	Share Based Compensation Arrangement By Share Based Payment Non Option Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentNonOptionAwardFairValueAssumptionsExercisePrice	6.16
CY2023Q2	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	4230850	usd
CY2023Q3	USAU	Change In Fair Value Of Warrant Liability ChangeInFairValueOfWarrantLiability	14950	usd
CY2023Q3	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	4215900	usd
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2023Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q3	USAU	Number Of Restrictred Stock Units Outstanding Vested And Unvested NumberOfRestrictredStockUnitsOutstandingVestedAndUnvested	433475	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	433475	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	9.57
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	433475	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	10.31
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	192750	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	5.54
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y5M8D
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	192750	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	5.54
CY2023Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y2M8D
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	179650	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	5.44
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	13100	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	6.93
CY2023Q3	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	7402	usd
CY2022Q3	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	7402	usd
CY2023Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	41940	usd
CY2023Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P1Y5M23D
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	2888949	shares
CY2023Q3	USAU	Share Based Compensation Arrangement By Share Based Payment Award Non Options Equity Instruments Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageExercisePrice	7.90
CY2023Q3	USAU	Weighted Average Remaining Contractual Life In Years Warrants Outstanding End Of Period WeightedAverageRemainingContractualLifeInYearsWarrantsOutstandingEndOfPeriod	P3Y10M24D
CY2023Q3	USAU	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisable	2018949	shares
CY2023Q3	USAU	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice	8.65
CY2023Q3	USAU	Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingIntrinsicValue	0	usd
CY2023Q3	USAU	Share Based Compensation Arrangement By Share Based Payment Award Non Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisesInPeriodTotalIntrinsicValue	0	usd
CY2023Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3515174	shares
CY2022Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2608411	shares
CY2023Q3	USAU	Lease Annual Payment Per Acre LeaseAnnualPaymentPerAcre	3.00
CY2023Q3	USAU	Production Royalties ProductionRoyalties	0.021	pure
CY2023Q3	USAU	Minimum Royalty Payments Percentage MinimumRoyaltyPaymentsPercentage	1	pure
CY2023Q3	USAU	Compensation For Loss CompensationForLoss	40.00	usd

Files In Submission

Name	View Source	Status
0001493152-23-032603-index-headers.html	Edgar Link	pending
0001493152-23-032603-index.html	Edgar Link	pending
0001493152-23-032603.txt	Edgar Link	pending
0001493152-23-032603-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
usau-20230731.xsd	Edgar Link	pending
usau-20230731_cal.xml	Edgar Link	unprocessable
usau-20230731_def.xml	Edgar Link	unprocessable
usau-20230731_lab.xml	Edgar Link	unprocessable
usau-20230731_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$USAU
US Gold Corp Stock $usau

2023 Q3 Form 10-Q Financial Statement

#000149315223032603 Filed on September 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$USAU US Gold Corp Stock $usau

2023 Q3 Form 10-Q Financial Statement

#000149315223032603 Filed on September 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$USAU
US Gold Corp Stock $usau